NADER EL-MALLAWANY to Rituximab
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about Rituximab.
Connection Strength
0.132
-
Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
Score: 0.112
-
Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S6-13.
Score: 0.020